1Boon DM van Vliet H H, Zietse R, el al. The presence of antibodies against a PF4-heparin complex in patients on haemodialysis [ J]. Thromb Haemost, 1996,76 ( 3 ) :480.
2Lindhnff-Last E, Nakov R, Misselwitz F,et al. Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecularweight heparin [ j ]. Br J Haematol, 2002,118 (4) : 1137 - 1142.
3Polkinghorne KR, McMahon LP, Becker GJ. Pharmacokinetic studies of dalteparin ( Fragmin), enoxaparin ( Clexane ), and danaparoid sodium (Orgaran) in stable chronic hemodialysis patients, A [J]. J Kid Dis,2002,40:990 -995.
4Stefoni S, Cianciolo G, Donati G, et ah Standard heparin versus low-molecular-weight heparin:a medium-term comparison in hemodialysis[ J ]. Nephron,2002,92:589 - 600.
5Shmitt Y, Sehneider H. The influence of low-molecular-weight heparin on blood lipoproteins in patients on chronic hemodialysis[ J ]. Atherosclerosis, 1997,134:49.
6Mori M,Yoshitake S, Kitano T, et al. Measurement of whole blood factor X a-activated clotting time during hemudialysis with low-molecular-weight heparin [ J ]. J Anesthesia, 1998,12 : 130 - 132.
3Bagshaw SM,Laupland KB,Boiteau PJ,et al.ls regional citratesuperior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system[J].J Crit Care,2005,20:155-161.
5Murray PT,Reddy BY,Grossman EJ,et al.A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease[J].Kidney Int,2004,66:2446-2453.
6Amanzadeh J,Reilly RF Jr.Anticoagulation and continuous renal replacement therapy[J].Semin Dial,2006,19(4):311-316.
7Hetzel GR,Sucker C.The heparin:all a nephrologist should know[J].Nephrol Dial Transplant,2005,20:2036-2042.
8Wiemer J,Winkler K,Baumstark M,et al.Influence of low molecular weight heparin compared to conventional heparin for anticoagulation during haemo-dialysis on low density lipoprotein subclasses[J].Nephrol Dial Transplant,2002,17:2231-2238.
10WADA H,ASAK UQAH,OKAMOTOK,etaI.Expert con sen sus for the treatment of disseminate ed intravacular coagulation in Japan[J].Thronlbin Res, 2010,125(1):6.
